University of Oxford double defence vaccine development

There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University.  An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both  antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing.  The information was provided to The Telegraph  by a senior source. Further media coverage will be reported on these developments on Monday 20th July.